Evidence map›Paper›PMID 36830885›Full record

ArticleBiomedicines2023

Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study.

Zsófia Kardos, Miklós Szabó, Zsuzsanna Baráth, Ágnes Miksi, Csaba Oláh, Ádám Kozma, József A Gergely, Eszter Csánky, Zoltán Szekanecz

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zsófia KardosDepartments of Rheumatology, Borsod Academic County Hospital, H-3529 Miskolc, Hungary.
Miklós SzabóDepartments of Pulmonology, Borsod Academic County Hospital, H-3529 Miskolc, Hungary.
Zsuzsanna BaráthDepartments of Rheumatology, Borsod Academic County Hospital, H-3529 Miskolc, Hungary.
Ágnes MiksiDepartments of Rheumatology, Borsod Academic County Hospital, H-3529 Miskolc, Hungary.
Csaba OláhDepartments of Neurosurgery, Borsod Academic County Hospital, H-3526 Miksolc, Hungary.
Ádám KozmaDepartments of Institutional Pharmacy, Borsod Academic County Hospital, H-3526 Miskolc, Hungary.
József A GergelyDepartments of Institutional Pharmacy, Borsod Academic County Hospital, H-3526 Miskolc, Hungary.
Eszter CsánkyDepartments of Pulmonology, Borsod Academic County Hospital, H-3529 Miskolc, Hungary.
Zoltán SzekaneczDepartment of Rheumatology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.ORCID 0000-0002-7794-6844
University of Miskolc · HUBorsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház · HUUniversity of Debrecen · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19efficacyIL-6 receptorpneumoniatocilizumab

Identifiers

PMID36830885
PMCPMC9953028
OpenAlexW4318208111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.